Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CD274 | Q9NZQ7 | 2/20 | 0.43 |
| ▸ | MRGPRX4 | Q96LA9 | 1/20 | 0.40 |
| ▸ | FFAR1 | O14842 | 11/20 | 0.38 |
| ▸ | PPARD | Q03181 | 6/20 | 0.38 |
| ▸ | HTR1A | P08908 | 2/20 | 0.37 |
| ▸ | DRD2 | P14416 | 2/20 | 0.37 |
| ▸ | HTR2A | P28223 | 1/20 | 0.37 |
| ▸ | PPARG | P37231 | 2/20 | 0.37 |
| ▸ | PPARA | Q07869 | 1/20 | 0.37 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25845452 | 0.86 | PPARD (0.47) | FFAR1PPARDPPARGPPARA | |
| SCHEMBL25845431 | 0.86 | PPARD (0.47) | FFAR1PPARDPPARGPPARA | |
| SCHEMBL25845564 | 0.84 | CD274 (0.41) | CD274MRGPRX4FFAR1PPARDHTR1A | |
| SCHEMBL25845547 | 0.84 | CD274 (0.44) | CD274MRGPRX4FFAR1PPARDHTR1A | |
| SCHEMBL25845538 | 0.84 | CD274 (0.42) | CD274MRGPRX4FFAR1PPARDHTR1A | |
| SCHEMBL25845559 | 0.82 | CD274 (0.40) | CD274MRGPRX4FFAR1PPARDHTR1A | |
| SCHEMBL25844242 | 0.82 | PPARD (0.59) | FFAR1PPARDPPARGPPARA | |
| SCHEMBL25846116 | 0.82 | PPARD (0.59) | FFAR1PPARDPPARGPPARA | |
| SCHEMBL25846272 | 0.80 | CD274 (0.42) | CD274MRGPRX4FFAR1PPARDPPARG | |
| SCHEMBL25846291 | 0.80 | MRGPRX4 (0.42) | CD274MRGPRX4FFAR1PPARDPPARG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4212528-A1 | BENZO OXYGEN-CONTAINING HETEROCYCLIC COMPOUND AND MEDICAL APPLICATION THEREOF | AB Pharma Ltd. (CN) | 2023-07-19 | — | — | EP | disclosed |